04:48 PM EDT, 05/06/2025 (MT Newswires) -- Andrew Lo, Director, on May 02, 2025, sold 100,000 shares in Bridgebio Pharma ( BBIO ) for $3,849,900. Following the Form 4 filing with the SEC, Lo has control over a total of 153,682 common shares of the company, with 48,099 shares held directly and 105,583 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000095017025064558/xslF345X05/ownership.xml